This is the second approval this week for a generic version of Wellbutrin, earlier this week Watson Pharmaceuticals announced it’s new version. BD
The Food and Drug Administration approved a generic copy of an antidepressant made by Impax Laboratories Inc.
Regulators gave the drug — a copy of GlaxoSmithKline ’s Wellbutrin XL 150 mg tablet — the nod on Nov. 26. Hayward-based Impax will start selling the drug as soon as it can.
Wellbutrin is a trade name of the drug bupropion, which works by slowing the absorption of dopamine and norepinephrine in the synapse between nerve cells.